LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

LLY

757.36

+3.2%↑

JNJ

151.29

+1.18%↑

UNH

291.24

+6.59%↑

ABBV

183.96

+1.27%↑

NVO

64.34

-2.56%↓

Search

STERIS PLC

Suletud

SektorTervishoid

252.04 2.45

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

243.99

Max

252.11

Põhinäitajad

By Trading Economics

Sissetulek

16M

173M

Müük

42M

1.4B

P/E

Sektori keskmine

37.416

56.602

Aktsiakasum

2.32

Dividenditootlus

1.01

Kasumimarginaal

12.643

Töötajad

18,000

EBITDA

44M

374M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+4.81% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.01%

2.45%

Järgmine tulemuste avaldamine

5. aug 2025

Järgmine dividendimakse kuupäev

26. juuni 2025

Järgmine aktsia dividendi kuupäev (ex-date)

10. juuni 2025

Turustatistika

By TradingEconomics

Turukapital

23B

Eelmine avamishind

249.59

Eelmine sulgemishind

252.04

Uudiste sentiment

By Acuity

50%

50%

173 / 382 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

STERIS PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. mai 2025, 20:30 UTC

Tulu

Steris Sees FY Adj EPS $9.90-Adj EPS $10.15 >STE

14. mai 2025, 20:30 UTC

Tulu

Steris 4Q Rev $1.5B >STE

14. mai 2025, 20:30 UTC

Tulu

Steris 4Q Adj EPS $2.74 >STE

5. veebr 2025, 21:35 UTC

Tulu

Steris: Outlook Does Not Reflect Any Potential Impact From New Tariffs >STE

5. veebr 2025, 21:34 UTC

Tulu

Steris: FY25 Guidance Change Is Primarily Due to Currency >STE

5. veebr 2025, 21:34 UTC

Tulu

Steris Cuts FY25 Revenue View to Increase of About 6% From Prior View for 6.5%-7%>STE

5. veebr 2025, 21:33 UTC

Tulu

Steris 3Q EPS $1.75 >STE

5. veebr 2025, 21:30 UTC

Tulu

Steris Sees FY Adj EPS $9.05-Adj EPS $9.15 >STE

5. veebr 2025, 21:30 UTC

Tulu

Steris 3Q Rev $1.4B >STE

5. veebr 2025, 21:30 UTC

Tulu

Steris 3Q Adj EPS $2.32 >STE

6. nov 2024, 21:41 UTC

Tulu

Steris Backs FY25 Revenue Up 6.5%-7.5% >STE

6. nov 2024, 21:40 UTC

Tulu

Steris 2Q EPS $1.51 >STE

6. nov 2024, 21:30 UTC

Tulu

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

6. nov 2024, 21:30 UTC

Tulu

Steris 2Q Adj EPS $2.14 >STE

6. nov 2024, 21:30 UTC

Tulu

Steris 2Q Rev $1.3B >STE

6. aug 2024, 20:36 UTC

Tulu

Steris 1Q Adj EPS $2.03 >STE

6. aug 2024, 20:30 UTC

Tulu

Steris 1Q Net $139.9M >STE

6. aug 2024, 20:30 UTC

Tulu

Steris 1Q EPS $1.41 >STE

6. aug 2024, 20:30 UTC

Tulu

Steris Sees FY Adj EPS $9.05-Adj EPS $9.25 >STE

3. juuni 2024, 11:03 UTC

Omandamised, ülevõtmised, äriostud

PEAK ROCK Cap Affil COMPLETES PREVIOUSLY ANNOUNCED ACQUISITION of HUFRIEDYGROUP

31. mai 2024, 20:47 UTC

Omandamised, ülevõtmised, äriostud

Steris Completes $787.5M Sale of Dental Segment to Peak Rock Capital

Võrdlus sarnastega

Hinnamuutus

STERIS PLC Prognoos

Hinnasiht

By TipRanks

4.81% tõus

12 kuu keskmine prognoos

Keskmine 258.75 USD  4.81%

Kõrge 280 USD

Madal 240 USD

Põhineb 5 Wall Streeti analüütiku instrumendi STERIS PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

3

Osta

2

Hoia

0

Müü

Tehniline skoor

By Trading Central

225 / 226.35Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

173 / 382 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest STERIS PLC

STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.